Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists
Appointment of seven recognized experts is validating for Ventyx’s NLRP3 Program--AD/PD™ 2025 provides helpful insights on potential next steps ...
Ventyx Biosciences announces seven additional appointments to SAB
Ventyx Biosciences (VTYX) announced the appointment of seven additional internationally-recognized scientists and clinicians to its Scientific ...